%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Luca Chierico, Loris Rizzello, Lijuan Guan, Adrian Steve Joseph, Andrew Lewis, Giuseppe Battaglia
The role of the two splice variants and extranuclear pathway on Ki-67 regulation in non-cancer and cancer cells
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 14 0 R/Contents 15 0 R/TrimBox[0 0 612 792]>>
endobj
14 0 obj
[16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R]
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171815.ref003)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171815.ref010)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171815.ref011)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171815.ref011)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171815.ref004)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171815.ref005)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171815.ref012)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171815.ref015)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171815.g001)>>
endobj
15 0 obj
[25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R]
endobj
25 0 obj
<>stream
q
0.83 0.64 0.02 0 k
387.6661 693.2976 m
392.4283 693.2976 l
h
f*
396.7937 693.2976 m
406.3181 693.2976 l
h
f*
543.1181 654.3496 m
552.6425 654.3496 l
h
f*
556.7244 615.3449 m
566.2488 615.3449 l
h
f*
203.4142 563.3008 m
208.1764 563.3008 l
h
f*
212.5984 563.3008 m
217.3606 563.3008 l
h
f*
221.8394 563.3008 m
231.3071 563.3008 l
h
f*
236.5228 563.3008 m
246.0472 563.3008 l
h
f*
321.9024 107.9433 m
341.4047 107.9433 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(It)Tj
0.856 0 Td
(should)Tj
2.9197 0 Td
(be)Tj
1.1508 0 Td
(mentioned)Tj
4.5808 0 Td
(that)Tj
1.7801 0 Td
(several)Tj
2.9367 0 Td
(studies)Tj
2.982 0 Td
(highlighted)Tj
4.7679 0 Td
(Ki-67)Tj
2.4604 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(strong)Tj
2.7723 0 Td
(prognostic)Tj
4.4844 0 Td
(biomarker)Tj
-33.3579 -1.3039 Td
(for)Tj
1.3776 0 Td
(both)Tj
2.0522 0 Td
(breast)Tj
2.6079 0 Td
(and)Tj
1.7235 0 Td
(non-small)Tj
4.2746 0 Td
(cell)Tj
1.5534 0 Td
(lung)Tj
2.0012 0 Td
(cancer)Tj
2.8346 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2529 0 Td
(10)Tj
0 g
(].)Tj
1.7348 0 Td
(This,)Tj
2.1997 0 Td
(in)Tj
1.0318 0 Td
(turn,)Tj
2.1827 0 Td
(has)Tj
1.5363 0 Td
(important)Tj
4.2747 0 Td
(implications)Tj
-32.6379 -1.2982 Td
(for)Tj
1.3832 0 Td
(the)Tj
1.4741 0 Td
(further)Tj
3.0273 0 Td
(selection)Tj
3.7191 0 Td
(and)Tj
1.7291 0 Td
(improvement)Tj
5.6692 0 Td
(of)Tj
1.0148 0 Td
(follow-up)Tj
4.0932 0 Td
(protocols/treatments)Tj
8.5663 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(radia-)Tj
-34.4237 -1.2983 Td
(tion,)Tj
2.0636 0 Td
(chemotherapy,)Tj
6.1738 0 Td
(and/or)Tj
2.9367 0 Td
(surgery.)Tj
-9.9779 -1.2983 Td
(Only)Tj
2.2166 0 Td
(very)Tj
1.9276 0 Td
(recently)Tj
3.4072 0 Td
(the)Tj
1.474 0 Td
(bio-molecular)Tj
5.845 0 Td
(function)Tj
3.634 0 Td
(of)Tj
1.0148 0 Td
(Ki-67)Tj
2.4605 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(finally)Tj
2.7042 0 Td
(uncovered)Tj
4.4277 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
2.0806 0 Td
(In)Tj
-36.0507 -1.3039 Td
(particular,)Tj
4.3369 0 Td
(Ki-67)Tj
2.4605 0 Td
(acts)Tj
1.7348 0 Td
(as)Tj
1.0148 0 Td
(surfactants)Tj
4.5694 0 Td
(and)Tj
1.7291 0 Td
(prevents)Tj
3.617 0 Td
(chromosomes)Tj
5.8507 0 Td
(from)Tj
2.2053 0 Td
(collapsing)Tj
4.235 0 Td
(into)Tj
1.8425 0 Td
(chroma-)Tj
-33.596 -1.2982 Td
(tin)Tj
1.3322 0 Td
(immediately)Tj
5.2044 0 Td
(after)Tj
2.0353 0 Td
(the)Tj
1.4683 0 Td
(disassembly)Tj
4.9833 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(nuclear)Tj
3.1918 0 Td
(membrane)Tj
4.5694 0 Td
(during)Tj
2.9254 0 Td
(cell)Tj
1.5647 0 Td
(division.)Tj
3.6453 0 Td
(This)Tj
-33.4032 -1.2983 Td
(allows)Tj
2.6985 0 Td
(correct)Tj
3.0387 0 Td
(chromosome)Tj
5.4879 0 Td
(motility)Tj
3.3732 0 Td
(and)Tj
1.7348 0 Td
(an)Tj
1.2019 0 Td
(effective)Tj
3.5092 0 Td
(interaction)Tj
4.6091 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4683 0 Td
(mitotic)Tj
3.1011 0 Td
(spindle)Tj
3.1125 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
-35.3308 -1.3039 Td
(Despite)Tj
3.2484 0 Td
(these)Tj
2.2507 0 Td
(promising)Tj
4.3427 0 Td
(data,)Tj
2.143 0 Td
(there)Tj
2.262 0 Td
(are)Tj
1.4513 0 Td
(however)Tj
3.6113 0 Td
(still)Tj
1.6384 0 Td
(a)Tj
0.652 0 Td
(high)Tj
2.0069 0 Td
(level)Tj
2.0183 0 Td
(of)Tj
1.0148 0 Td
(uncertainty,)Tj
5.04 0 Td
(especially)Tj
-31.6798 -1.2983 Td
(regarding)Tj
4.0932 0 Td
(the)Tj
1.4683 0 Td
(exact)Tj
2.2677 0 Td
(function)Tj
3.6283 0 Td
(of)Tj
1.0148 0 Td
(each)Tj
2.0239 0 Td
(Ki-67)Tj
2.4662 0 Td
(splice)Tj
2.4604 0 Td
(variant)Tj
3.0274 0 Td
(\(the)Tj
/F13 1 Tf
1.8085 0 Td
()Tj
/F8 1 Tf
0.788 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
/F13 1 Tf
1.4741 0 Td
()Tj
/F8 1 Tf
(\).)Tj
1.2699 0 Td
(Many)Tj
2.5511 0 Td
(efforts)Tj
2.7553 0 Td
(have)Tj
-34.8262 -1.2983 Td
(been)Tj
2.1203 0 Td
(mainly)Tj
2.9933 0 Td
(focused)Tj
3.2768 0 Td
(toward)Tj
3.0444 0 Td
(the)Tj
1.4684 0 Td
(exploration)Tj
4.8018 0 Td
(of)Tj
1.0148 0 Td
(Ki-67)Tj
2.4662 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6519 0 Td
(specific)Tj
3.1918 0 Td
(structural)Tj
4.0819 0 Td
(nuclear)Tj
3.1918 0 Td
(element)Tj
-33.3182 -1.3039 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2585 0 Td
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
0.9241 0 Td
(12)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
3.2031 0 Td
(However,)Tj
4.0762 0 Td
(there)Tj
2.2677 0 Td
(are)Tj
1.4457 0 Td
(not)Tj
1.5761 0 Td
(specific)Tj
3.1917 0 Td
(studies)Tj
2.9821 0 Td
(available)Tj
3.668 0 Td
(on)Tj
1.2756 0 Td
(potential)Tj
3.7587 0 Td
(extra-nuclear)Tj
5.5388 0 Td
(Ki-67)Tj
-35.1663 -1.2982 Td
(pathways,)Tj
4.1555 0 Td
(in)Tj
1.0375 0 Td
(order)Tj
2.4208 0 Td
(to)Tj
1.0204 0 Td
(better)Tj
2.5455 0 Td
(understand)Tj
4.7905 0 Td
(its)Tj
1.1452 0 Td
(possible)Tj
3.4073 0 Td
(fate)Tj
1.6667 0 Td
(beyond)Tj
3.1861 0 Td
(the)Tj
1.4684 0 Td
(nucleus)Tj
3.2825 0 Td
(as)Tj
1.0148 0 Td
(well.)Tj
2.0409 0 Td
(In)Tj
1.1112 0 Td
(addi-)Tj
-34.2933 -1.2983 Td
(tion,)Tj
2.0636 0 Td
(we)Tj
1.3266 0 Td
(still)Tj
1.644 0 Td
(miss)Tj
2.024 0 Td
(the)Tj
1.474 0 Td
(bigger)Tj
2.7156 0 Td
(picture)Tj
3.05 0 Td
(on)Tj
1.2756 0 Td
(how)Tj
1.9389 0 Td
(the)Tj
1.4683 0 Td
(two)Tj
1.7121 0 Td
(splice)Tj
2.4548 0 Td
(variants)Tj
3.3902 0 Td
(are)Tj
1.4514 0 Td
(regulated,)Tj
4.1612 0 Td
(especially)Tj
4.0195 0 Td
(in)Tj
-36.1698 -1.3039 Td
(different)Tj
3.6566 0 Td
(cells.)Tj
-2.4604 -1.2983 Td
(In)Tj
1.1111 0 Td
(this)Tj
1.6725 0 Td
(work,)Tj
2.5058 0 Td
(we)Tj
1.3266 0 Td
(explored)Tj
3.702 0 Td
(new)Tj
1.8765 0 Td
(avenues)Tj
3.3959 0 Td
(in)Tj
1.0318 0 Td
(Ki-67)Tj
2.4661 0 Td
(regulation)Tj
4.3087 0 Td
(in)Tj
1.0318 0 Td
(cancerous)Tj
4.2406 0 Td
(and)Tj
1.7291 0 Td
(non-cancerous)Tj
-31.5947 -1.2982 Td
(cells,)Tj
2.1429 0 Td
(especially)Tj
4.0195 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(viewpoint)Tj
4.184 0 Td
(of)Tj
1.0147 0 Td
(addressing)Tj
4.5071 0 Td
(a)Tj
0.6576 0 Td
(relation)Tj
3.3166 0 Td
(between)Tj
3.5262 0 Td
(the)Tj
1.4684 0 Td
(proliferation)Tj
5.2667 0 Td
(activity)Tj
3.1181 0 Td
(of)Tj
-35.7276 -1.2983 Td
(cells)Tj
1.9218 0 Td
(and)Tj
1.7292 0 Td
(the)Tj
1.4683 0 Td
(splice)Tj
2.4604 0 Td
(variants)Tj
3.3846 0 Td
(expressed,)Tj
4.32 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(with)Tj
2.0012 0 Td
(the)Tj
1.4684 0 Td
(protein)Tj
3.1521 0 Td
(degradation)Tj
5.0229 0 Td
(pathway.)Tj
-29.5821 -1.3039 Td
(We)Tj
1.61 0 Td
(first)Tj
1.8085 0 Td
(studied)Tj
3.1521 0 Td
(the)Tj
1.4684 0 Td
(expression)Tj
4.4673 0 Td
(profile)Tj
2.8403 0 Td
(and)Tj
1.7292 0 Td
(cellular)Tj
3.1407 0 Td
(localisation)Tj
4.7565 0 Td
(of)Tj
1.0148 0 Td
(Ki-67)Tj
2.4662 0 Td
(in)Tj
1.0318 0 Td
(different)Tj
3.6566 0 Td
(cells,)Tj
-34.3386 -1.2983 Td
(namely)Tj
3.1464 0 Td
(in)Tj
1.0375 0 Td
(non-cancerous)Tj
6.1908 0 Td
(primary)Tj
3.4582 0 Td
(human)Tj
3.0784 0 Td
(dermal)Tj
3.0388 0 Td
(fibroblasts)Tj
4.371 0 Td
(\(HDF\))Tj
2.931 0 Td
(and)Tj
1.7291 0 Td
(human)Tj
3.0784 0 Td
(umbilical)Tj
-32.0596 -1.2983 Td
(vein)Tj
1.9105 0 Td
(endothelial)Tj
4.6715 0 Td
(cells)Tj
1.9218 0 Td
(\(HUVEC\),)Tj
4.5581 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(in)Tj
1.0318 0 Td
(human)Tj
3.0784 0 Td
(breast)Tj
2.6136 0 Td
(cancer)Tj
2.8459 0 Td
(cells)Tj
1.9219 0 Td
(\(MDA-MB-231\),)Tj
-28.4029 -1.3039 Td
(human)Tj
3.0784 0 Td
(cervix)Tj
2.6248 0 Td
(adenocarcinoma)Tj
6.8882 0 Td
(cells)Tj
1.9218 0 Td
(\(HeLa\),)Tj
3.2882 0 Td
(and)Tj
1.7291 0 Td
(hypopharyngeal)Tj
6.6501 0 Td
(carcinoma)Tj
4.4447 0 Td
(cells)Tj
1.9218 0 Td
(\(FaDu\).)Tj
-32.5471 -1.2982 Td
(This)Tj
1.9842 0 Td
(preliminary)Tj
4.9436 0 Td
(investigation)Tj
5.3574 0 Td
(enabled)Tj
3.3335 0 Td
(us)Tj
1.1056 0 Td
(to)Tj
1.0261 0 Td
(understand)Tj
4.7905 0 Td
(how)Tj
1.9389 0 Td
(different)Tj
3.6567 0 Td
(cells)Tj
1.9162 0 Td
(regulate)Tj
3.4129 0 Td
(the)Tj
1.4683 0 Td
(pro-)Tj
-34.9339 -1.2983 Td
(tein)Tj
1.7574 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(function)Tj
3.6283 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(different)Tj
3.6567 0 Td
(steps)Tj
2.1827 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(interphase.)Tj
4.6204 0 Td
(Then,)Tj
2.5569 0 Td
(we)Tj
1.3266 0 Td
(focused)Tj
3.2768 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4683 0 Td
(possible)Tj
-32.3827 -1.3039 Td
(relationship)Tj
4.9889 0 Td
(between)Tj
3.5263 0 Td
(the)Tj
1.4683 0 Td
(two)Tj
1.7121 0 Td
(main)Tj
2.2904 0 Td
(splice)Tj
2.4548 0 Td
(variants)Tj
3.3902 0 Td
(of)Tj
1.0148 0 Td
(Ki-67)Tj
2.4661 0 Td
(and)Tj
1.7292 0 Td
(the)Tj
1.4683 0 Td
(cellular)Tj
3.1408 0 Td
(control)Tj
3.118 0 Td
(over)Tj
1.9786 0 Td
(prolif-)Tj
-34.7468 -1.2983 Td
(eration.)Tj
3.2938 0 Td
(Together)Tj
3.8494 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4683 0 Td
(control)Tj
3.1238 0 Td
(over)Tj
1.9786 0 Td
(the)Tj
1.4683 0 Td
(transcriptional)Tj
6.1115 0 Td
(regulation)Tj
4.3086 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(specific)Tj
3.1918 0 Td
(variants,)Tj
-33.2728 -1.2983 Td
(imaging)Tj
3.4865 0 Td
(investigations)Tj
5.7203 0 Td
(further)Tj
3.0274 0 Td
(confirmed)Tj
4.3993 0 Td
(that)Tj
1.7745 0 Td
(cells)Tj
1.9219 0 Td
(control)Tj
3.1238 0 Td
(the)Tj
1.4683 0 Td
(post-translational)Tj
7.2453 0 Td
(expression)Tj
4.4674 0 Td
(of)Tj
-36.6347 -1.2982 Td
(Ki-67)Tj
2.4604 0 Td
(via)Tj
1.3776 0 Td
(proteasome)Tj
4.8813 0 Td
(degradation.)Tj
-7.5231 -1.3039 Td
(Finally,)Tj
3.1747 0 Td
(quantitative)Tj
4.9777 0 Td
(imaging)Tj
3.4865 0 Td
(confocal)Tj
3.5944 0 Td
(assays)Tj
2.6248 0 Td
(surprisingly)Tj
4.9833 0 Td
(suggest)Tj
3.1181 0 Td
(that)Tj
1.7801 0 Td
(Ki-67)Tj
2.4605 0 Td
(may)Tj
1.9332 0 Td
(be)Tj
1.1452 0 Td
(translo-)Tj
-34.4747 -1.2983 Td
(cated)Tj
2.3243 0 Td
(outside)Tj
3.1351 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(nucleus)Tj
3.2768 0 Td
(in)Tj
1.0375 0 Td
(non-cancerous)Tj
6.1965 0 Td
(cells,)Tj
2.143 0 Td
(resulting)Tj
3.7303 0 Td
(in)Tj
1.0375 0 Td
(accumulation)Tj
5.6749 0 Td
(within)Tj
2.812 0 Td
(the)Tj
-33.8511 -1.2983 Td
(endoplasmic)Tj
5.295 0 Td
(reticulum)Tj
4.1216 0 Td
(first,)Tj
2.0352 0 Td
(and)Tj
1.7292 0 Td
(the)Tj
1.4683 0 Td
(Golgi)Tj
2.4208 0 Td
(apparatus)Tj
4.1159 0 Td
(later.)Tj
2.2166 0 Td
(This)Tj
1.9899 0 Td
(transfer)Tj
3.3166 0 Td
(mechanism)Tj
4.8415 0 Td
(seemed)Tj
-33.5506 -1.3039 Td
(significantly)Tj
5.0853 0 Td
(less)Tj
1.6157 0 Td
(efficient)Tj
3.4469 0 Td
(in)Tj
1.0375 0 Td
(cancerous)Tj
4.2349 0 Td
(cells.)Tj
2.1487 0 Td
(This)Tj
1.9842 0 Td
(would)Tj
2.7156 0 Td
(support)Tj
3.3222 0 Td
(the)Tj
1.4683 0 Td
(idea)Tj
1.8709 0 Td
(that)Tj
1.7801 0 Td
(extranuclear)Tj
-30.7103 -1.2982 Td
(effectors)Tj
3.5999 0 Td
(may)Tj
1.9332 0 Td
(finely)Tj
2.4435 0 Td
(regulate)Tj
3.4129 0 Td
(the)Tj
1.4683 0 Td
(degradation)Tj
5.023 0 Td
(of)Tj
1.0148 0 Td
(Ki-67,)Tj
2.6872 0 Td
(and)Tj
1.7348 0 Td
(that)Tj
1.7745 0 Td
(the)Tj
1.474 0 Td
(transfer)Tj
3.3165 0 Td
(between)Tj
3.5263 0 Td
(the)Tj
1.4683 0 Td
(differ-)Tj
-34.8772 -1.2983 Td
(ent)Tj
1.491 0 Td
(stages)Tj
2.5625 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(interphase)Tj
4.3937 0 Td
(of)Tj
1.0148 0 Td
(cell)Tj
1.559 0 Td
(cycle)Tj
2.1883 0 Td
(is)Tj
0.8504 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4684 0 Td
(cytosolic)Tj
3.7077 0 Td
(fate)Tj
1.6667 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(protein,)Tj
3.3788 0 Td
(and)Tj
-35.5008 -1.3039 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.4684 0 Td
(specific)Tj
3.1918 0 Td
(splice)Tj
2.4604 0 Td
(variant)Tj
3.0274 0 Td
(present.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 234.9921 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Results)Tj
/F0 1 Tf
0 -1.4976 Td
(Quantification)Tj
6.2598 0 Td
(of)Tj
1.0489 0 Td
(Ki-67)Tj
2.5228 0 Td
(expression)Tj
4.9938 0 Td
(in)Tj
0.9826 0 Td
(different)Tj
3.7938 0 Td
(cell)Tj
1.6913 0 Td
(models)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 200.0125 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(first)Tj
1.8085 0 Td
(experimental)Tj
5.4538 0 Td
(approach)Tj
3.9572 0 Td
(aimed)Tj
2.6872 0 Td
(to)Tj
1.0261 0 Td
(quantify)Tj
3.549 0 Td
(and)Tj
1.7291 0 Td
(localise)Tj
3.1294 0 Td
(the)Tj
1.4684 0 Td
(intracellular)Tj
5.0569 0 Td
(Ki-67)Tj
2.4605 0 Td
(in)Tj
1.0375 0 Td
(non-)Tj
-35.1437 -1.3039 Td
(cancerous)Tj
4.2406 0 Td
(and)Tj
1.7291 0 Td
(cancerous)Tj
4.2406 0 Td
(cells,)Tj
2.143 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(function)Tj
3.6283 0 Td
(of)Tj
1.0148 0 Td
(their)Tj
2.109 0 Td
(proliferative)Tj
5.0853 0 Td
(or)Tj
1.0998 0 Td
(quiescent)Tj
4.0025 0 Td
(phases.)Tj
3.0671 0 Td
(Immu-)Tj
-34.0325 -1.2982 Td
(nofluorescence)Tj
6.2418 0 Td
(investigations)Tj
5.7203 0 Td
(were)Tj
2.1203 0 Td
(carried)Tj
3.0387 0 Td
(out)Tj
1.5534 0 Td
(on)Tj
1.2756 0 Td
(HDF)Tj
2.2563 0 Td
(and)Tj
1.7291 0 Td
(HUVEC)Tj
3.651 0 Td
(\(non-cancerous)Tj
6.531 0 Td
(cells\),)Tj
2.4888 0 Td
(as)Tj
-36.6063 -1.2983 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(on)Tj
1.2756 0 Td
(MDA-MB-231,)Tj
6.3552 0 Td
(FaDu,)Tj
2.6759 0 Td
(and)Tj
1.7291 0 Td
(HeLa)Tj
2.3811 0 Td
(cells)Tj
1.9219 0 Td
(\(cancerous)Tj
4.5807 0 Td
(cells\),)Tj
2.4832 0 Td
(co-labelling)Tj
4.8869 0 Td
(them)Tj
2.2903 0 Td
(with)Tj
1.9956 0 Td
(fluo-)Tj
-35.4101 -1.2983 Td
(rescent)Tj
3.067 0 Td
(anti-Ki-67)Tj
4.3597 0 Td
(antibodies)Tj
4.3653 0 Td
(and)Tj
1.7291 0 Td
(with)Tj
1.9956 0 Td
(SYTO)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 379.8425 152.4472 cm
BT
/F14 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 387.3259 148.0251 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(9)Tj
0.6973 0 Td
(for)Tj
1.3833 0 Td
(nuclear)Tj
3.1974 0 Td
(staining.)Tj
3.634 0 Td
(Cells)Tj
2.16 0 Td
(were)Tj
2.1203 0 Td
(incubated)Tj
4.1782 0 Td
(in)Tj
-36.1017 -1.3039 Td
(both)Tj
2.058 0 Td
(normal)Tj
3.1464 0 Td
(and)Tj
1.7291 0 Td
(Fetal)Tj
2.1543 0 Td
(Bovine)Tj
2.9991 0 Td
(Serum)Tj
2.8346 0 Td
(\(FBS\))Tj
2.4831 0 Td
(deprived)Tj
3.736 0 Td
(media)Tj
2.6929 0 Td
(to)Tj
1.0261 0 Td
(control)Tj
3.1181 0 Td
(the)Tj
1.474 0 Td
(proliferation)Tj
5.2611 0 Td
(status.)Tj
-34.7128 -1.2982 Td
(We)Tj
1.6101 0 Td
(found)Tj
2.6192 0 Td
(high)Tj
2.0069 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(Ki-67)Tj
2.4605 0 Td
(at)Tj
0.9524 0 Td
(nuclear)Tj
3.1975 0 Td
(level)Tj
2.0126 0 Td
(immediately)Tj
5.1986 0 Td
(after)Tj
2.0352 0 Td
(starvation)Tj
4.1953 0 Td
(\(time)Tj
2.3697 0 Td
(zero\))Tj
2.2734 0 Td
(of)Tj
1.0148 0 Td
(pri-)Tj
-35.3364 -1.2983 Td
(mary)Tj
2.2961 0 Td
(HDF)Tj
2.2507 0 Td
(and)Tj
1.7291 0 Td
(HUVEC)Tj
3.651 0 Td
(cells)Tj
1.9219 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8141 0 Td
(1)Tj
0 g
(,)Tj
0.9241 0 Td
(top-left\).)Tj
3.7134 0 Td
(However,)Tj
4.0761 0 Td
(the)Tj
1.4683 0 Td
(amount)Tj
3.3505 0 Td
(of)Tj
1.0148 0 Td
(protein)Tj
3.1522 0 Td
(becomes)Tj
3.685 0 Td
(signif-)Tj
-35.0473 -1.3039 Td
(icant)Tj
2.1884 0 Td
(less)Tj
1.6157 0 Td
(after)Tj
2.0353 0 Td
(18)Tj
1.1678 0 Td
(hours)Tj
2.5172 0 Td
(of)Tj
1.0148 0 Td
(starvation)Tj
4.1952 0 Td
(time,)Tj
2.2507 0 Td
(and)Tj
1.7291 0 Td
(it)Tj
0.788 0 Td
(is)Tj
0.8447 0 Td
(completely)Tj
4.5807 0 Td
(undetected)Tj
4.6432 0 Td
(after)Tj
2.0352 0 Td
(36)Tj
1.1736 0 Td
(hours)Tj
2.5114 0 Td
(of)Tj
-35.291 -1.2983 Td
(FBS)Tj
1.8029 0 Td
(deprivation,)Tj
5.0626 0 Td
(when)Tj
2.4038 0 Td
(cells)Tj
1.9218 0 Td
(enter)Tj
2.2848 0 Td
(the)Tj
1.4683 0 Td
(quiescent)Tj
3.9967 0 Td
(phase.)Tj
2.7099 0 Td
(On)Tj
1.5194 0 Td
(the)Tj
1.4683 0 Td
(other)Tj
2.3471 0 Td
(hand,)Tj
2.4831 0 Td
(Ki-67)Tj
2.4605 0 Td
(is)Tj
0.8504 0 Td
(always)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 361.0204 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Ki-67)Tj
2.5086 0 Td
(out)Tj
1.5874 0 Td
(of)Tj
1.0418 0 Td
(the)Tj
1.5874 0 Td
(box:)Tj
2.0764 0 Td
(extracellu)Tj
4.1953 0 Td
(lar)Tj
1.311 0 Td
(pathway)Tj
3.6568 0 Td
(s)Tj
0.7157 0 Td
(and)Tj
1.8567 0 Td
(role)Tj
1.8496 0 Td
(of)Tj
1.0418 0 Td
(variants)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0171)Tj
3.5434 0 Td
(815)Tj
2.6362 0 Td
(February)Tj
4.1599 0 Td
(10,)Tj
1.5874 0 Td
(2017)Tj
37.3538 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(20)Tj
/F10 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F11 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(received)Tj
3.3024 0 Td
(funding)Tj
-16.1221 -1.3748 Td
(from)Tj
2.0126 0 Td
(Biocom)Tj
2.8346 0 Td
(patibles)Tj
3.0756 0 Td
(UK)Tj
1.3323 0 Td
(Ltd,)Tj
1.6441 0 Td
(a)Tj
0.6449 0 Td
(commerci)Tj
3.7418 0 Td
(al)Tj
-15.2859 -1.3749 Td
(company,)Tj
3.8834 0 Td
(for)Tj
1.2544 0 Td
(this)Tj
1.5661 0 Td
(study.)Tj
2.4875 0 Td
(There)Tj
2.3173 0 Td
(are)Tj
1.3677 0 Td
(no)Tj
1.1693 0 Td
(patents,)Tj
-14.0457 -1.3748 Td
(products)Tj
3.522 0 Td
(in)Tj
0.8859 0 Td
(developm)Tj
3.6283 0 Td
(ent)Tj
1.3678 0 Td
(or)Tj
1.0063 0 Td
(markete)Tj
2.9976 0 Td
(d)Tj
0.6945 0 Td
(products)Tj
3.5221 0 Td
(to)Tj
-17.6245 -1.3748 Td
(declare.)Tj
3.1039 0 Td
(This)Tj
1.7788 0 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4244 0 Td
(alter)Tj
1.8142 0 Td
(our)Tj
1.474 0 Td
(adherence)Tj
4.0536 0 Td
(to)Tj
0.9496 0 Td
(all)Tj
1.0276 0 Td
(the)Tj
-17.6387 -1.3748 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
1.8708 0 Td
(policies)Tj
3.0119 0 Td
(on)Tj
1.1622 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
1.7929 0 Td
(and)Tj
ET
endstream
endobj
26 0 obj
<>stream
endstream
endobj
27 0 obj
<>stream
endstream
endobj
28 0 obj
<>stream
endstream
endobj
29 0 obj
<>stream
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
BT
14.7402 77.2163 Td
(materials.)Tj
ET
Q
endstream
endobj
36 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 41 0 R/Contents 42 0 R/TrimBox[0 0 612 792]>>
endobj
40 0 obj
<>stream
JFIF C
$, !$4.763.22:ASF:=N>22HbINVX]^]8EfmeZlS[]Y C**Y;2;YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY "
} !1AQa"q2#BR$3br
%&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz
w !1AQaq"2B #3Rbr
$4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ? (
(
(
(
(
(
(
(
(
(
(
()꺌:N-»E2# $zZ6iZ}ћ O9 J ŮKmCYkp~rȣFd 5}.nWGF@ GOwV75+E_K8.chE
23՟ȿ_ ,]g \tfKZ8Ln:XGc@M KEQWӭyo)>ycOiym{k